投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
8.4 %
年文章数
1198
作者需知
暂无数据
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
Nuclear Medicine and Biology is intended for original research contributions describing original synthesis, in vitro tissue studies, or in vivo use of radiotracers, radiopharmaceuticals, or therapeutic agents. Papers concentrate on the synthesis, testing in vitro, and examination of a compound in vivo. Extensive studies proving the mechanism of localization in vivo whether the radioactive substance is based on receptor-, enzyme-, or tumor antigen-binding or other well defined processes are an integral part of each evaluation. Additionally, studies should define a significant compound that is a sensitive probe of a biochemical change in vivo.
